India
UK
Africa

Choose another country or region to see content specific to your location

COVID-19

Home > News

Covaxin gets SEC approval: Getting the experts’ perspective

IPE Global | News | October 12, 2021 IST

Covaxin gets SEC approval: Getting the experts’ perspective

Bharat Biotech’s Covaxin received nod from Subject Expert Committee (SEC) on Tuesday who further proffered positive recommendation to DCGI for the use of Covaxin in 2-18 years age group. Bharat Biotech has earlier submitted data from clinical trials to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for emergency use authorisation (EUA) for the jab at the beginning of this month.

 

Click here to know more..



Related News


No related news found.